InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the complete record of transactions filed by Mattsson Jan, Dirigeant. Insider active across 1 companies, notably Albireo Pharma, INC.. Cumulatively, 5 disclosures have been published. Total volume traded: €42k. The latest transaction was disclosed on 22 April 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
200 shares@ €30.386914.6% of flowCommon StockSEC:0001209191-22-025526:0
808 shares@ €21.9391100.0% of flowCommon StockSEC:0001209191-22-004803
808 shares@ €21.939142.7% of flowCommon StockSEC:0001209191-22-004803:0
21,600 shares0Common StockSEC:0001209191-22-004068:0
21,600 shares0Common StockSEC:0001209191-22-004068
5 of 5 declarations
About Mattsson Jan
Jan Mattsson is the Chief Scientific Officer at Albireo Pharma, Inc. In this role, he is responsible for the scientific direction and innovation within the company. His expertise in the pharmaceutical field contributes to the development of new treatments and the advancement of the company's research goals.
